Healthcare provider profile · identity verified

Krysta Hrdlichka, PA-C

Physician Assistant · HASTINGS, MN · NPI 1063824696

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	270	72
Losartan Potassium	Losartan Potassium	226	53
Omeprazole	Omeprazole	203	60
Amlodipine Besylate	Amlodipine Besylate	189	64
Levothyroxine Sodium	Levothyroxine Sodium	154	39
Gabapentin	Gabapentin	148	43
Lisinopril	Lisinopril	124	37
Metoprolol Succinate	Metoprolol Succinate	116	30
Hydrochlorothiazide	Hydrochlorothiazide	110	30
Albuterol Sulfate Hfa	Albuterol Sulfate	104	38
Famotidine	Famotidine	104	34
Atenolol	Atenolol	99	28
Warfarin Sodium	Warfarin Sodium	93	13
Furosemide	Furosemide	90	35
Prednisone	Prednisone	90	70
Trazodone Hcl	Trazodone Hcl	84	25
Metformin Hcl Er	Metformin Hcl	82	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	79	17
Simvastatin	Simvastatin	72	16
Rosuvastatin Calcium	Rosuvastatin Calcium	68	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	67	12
Potassium Chloride	Potassium Chloride	65	14
Fluoxetine Hcl	Fluoxetine Hcl	64	16
Tizanidine Hcl	Tizanidine Hcl	63	26
Pantoprazole Sodium	Pantoprazole Sodium	62	18
Tramadol Hcl	Tramadol Hcl	60	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	57	11
Metformin Hcl	Metformin Hcl	53	13
Eliquis	Apixaban	52	17
Montelukast Sodium	Montelukast Sodium	51	16
Lorazepam	Lorazepam	49	15
Metoprolol Tartrate	Metoprolol Tartrate	49	14
Duloxetine Hcl	Duloxetine Hcl	46	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	46	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	suppressed
Citalopram Hbr	Citalopram Hydrobromide	42	11
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	35
Escitalopram Oxalate	Escitalopram Oxalate	37	13
Buspirone Hcl	Buspirone Hcl	36	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	suppressed
Allopurinol	Allopurinol	35	12
Glipizide Er	Glipizide	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Jardiance	Empagliflozin	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	30
Mirtazapine	Mirtazapine	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	32	11
Topiramate	Topiramate	31	suppressed
Torsemide	Torsemide	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	20
Valacyclovir	Valacyclovir Hcl	30	13
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Ketoconazole	Ketoconazole	29	16
Nystatin	Nystatin	29	13
Ezetimibe	Ezetimibe	28	suppressed
Spironolactone	Spironolactone	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Mounjaro	Tirzepatide	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Sertraline Hcl	Sertraline Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	15
Ibuprofen	Ibuprofen	24	suppressed
Naltrexone Hcl	Naltrexone Hcl	24	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	21	suppressed
Glipizide	Glipizide	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Carvedilol	Carvedilol	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Azithromycin	Azithromycin	19	17
Bumetanide	Bumetanide	18	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Colchicine	Colchicine	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Estradiol	Estradiol	18	suppressed
Nitroglycerin	Nitroglycerin	18	11
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Ozempic	Semaglutide	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Levofloxacin	Levofloxacin	16	16
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Finasteride	Finasteride	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	14
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Olanzapine Odt	Olanzapine	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Dayvigo	Lemborexant	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Doxycycline Monohydrate	Doxycycline Monohydrate	12	11
Nifedipine Er	Nifedipine	12	suppressed
Lovastatin	Lovastatin	11	suppressed
Omnipod Dash Pods (Gen 4)	Insulin Pump Cart,cont Inf,bt	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error